Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
19388 | 443 | 33.8 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
324 | 17505 | HYPERALGESIA//NEUROPATHIC PAIN//ANTINOCICEPTION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEOSTIGMINE | Author keyword | 4 | 12% | 8% | 35 |
2 | INTRATHECAL NEOSTIGMINE | Author keyword | 4 | 75% | 1% | 3 |
3 | HOSP CLINDISCIPLINE ANESTHESIOL | Address | 2 | 67% | 0% | 2 |
4 | NEUROTRANSMITTERS ACETYLCHOLINE | Author keyword | 2 | 67% | 0% | 2 |
5 | BIOMECH MED REHABIL LOCOMOTOR MEMBERS | Address | 1 | 50% | 0% | 2 |
6 | CEREBROSPINAL FLUID COMPONENTS ACETYLCHOLINE NOREPINEPHRINE | Author keyword | 1 | 100% | 0% | 2 |
7 | CHOLINESTERASE INHIBITORS NEOSTIGMINE | Author keyword | 1 | 100% | 0% | 2 |
8 | M4 MUSCARINE ACETYLCHOLINE RECEPTOR | Author keyword | 1 | 100% | 0% | 2 |
9 | NEOSTIGMINE EPIDURAL | Author keyword | 1 | 100% | 0% | 2 |
10 | R HYOSCYAMINE | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTRATHECAL NEOSTIGMINE | 73 | 71% | 13% | 59 |
2 | METHYLSULFATE | 19 | 50% | 6% | 27 |
3 | SPINAL CHOLINESTERASE INHIBITION | 14 | 100% | 2% | 7 |
4 | POSTCESAREAN SECTION ANALGESIA | 10 | 73% | 2% | 8 |
5 | EPIDURAL NEOSTIGMINE | 5 | 63% | 1% | 5 |
6 | GLYCINERGIC INPUT | 4 | 75% | 1% | 3 |
7 | CHOLINERGIC ANALGESIA | 3 | 100% | 1% | 3 |
8 | SUBARACHNOID NEOSTIGMINE | 3 | 100% | 1% | 3 |
9 | TONIC CHOLINERGIC INHIBITION | 2 | 43% | 1% | 3 |
10 | ISOLATED RAT SKIN | 1 | 21% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Targeting the cholinergic system as a therapeutic strategy for the treatment of pain | 2007 | 50 | 92 | 49% |
Use of neostigmine in the management of acute postoperative pain and labour pain - A review | 2006 | 12 | 69 | 86% |
A systematic review of the effects of adding neostigmine to local anesthetics for neuraxial administration in obstetric anesthesia and analgesia | 2015 | 0 | 31 | 65% |
Modulation of pain transmission by G-protein-coupled receptors | 2008 | 57 | 311 | 8% |
Combination spinal analgesic chemotherapy: A systematic review | 2002 | 54 | 131 | 16% |
Easing Human Pain: Challenges to a Novel Therapeutic Drug in Neuropathic Pain | 2014 | 0 | 23 | 35% |
Donepezil in the treatment of opioid-induced sedation: Report of six cases | 2001 | 14 | 79 | 25% |
Involvement of the intralaminar parafascicular nucleus in muscarinic-induced antinociception in rats | 2004 | 17 | 80 | 18% |
ANTINOCICEPTION OPIOIDS AND THE CHOLINERGIC SYSTEM | 1986 | 40 | 48 | 29% |
You May Need a Nerve to Treat Pain The Neurobiological Rationale for Vagal Nerve Activation in Pain Management | 2014 | 0 | 68 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HOSP CLINDISCIPLINE ANESTHESIOL | 2 | 67% | 0.5% | 2 |
2 | BIOMECH MED REHABIL LOCOMOTOR MEMBERS | 1 | 50% | 0.5% | 2 |
3 | NEURAL ALGESIA ELE OPHYSIOL | 1 | 40% | 0.5% | 2 |
4 | SURG ORTHOPED TRAUMATOL | 1 | 25% | 0.7% | 3 |
5 | DEPARTIMENTO BIOL ANIM | 1 | 50% | 0.2% | 1 |
6 | DISCIPLINE ANESTHESIA PAIN MANAGEMENT | 1 | 50% | 0.2% | 1 |
7 | DIST GEN HOSP | 1 | 50% | 0.2% | 1 |
8 | HUMAN PHYSIOL REHABIL SCI | 1 | 50% | 0.2% | 1 |
9 | MED INVEST LIM 08 | 1 | 50% | 0.2% | 1 |
10 | NEUROINFLAMACAO | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000202914 | 2 SEC BUTYLPHENYL METHYLCARBAMATE BPMC//CENTRAL CHOLINERGIC SYSTEMS//CHOLINERGIC HYPERTENSION |
2 | 0.0000160257 | GRP NEUROFARMACOL MOL//PERIPHERAL ANTINOCICEPTION//NO RELEASING COMPOUNDS |
3 | 0.0000130728 | 3RD MESSENGER//LEARNED HELPLESSNESS BEHAVIOR//MARKER ENZYME |
4 | 0.0000127541 | INTRATHECAL MIDAZOLAM//JM 1232//ISOINDOLIN 1 ONE DERIVATIVE |
5 | 0.0000124907 | PSYCHOGENIC COMA//CENTRAL ANTICHOLINERGIC SYNDROME//ATROPINE OVERDOSE |
6 | 0.0000099672 | DEXMEDETOMIDINE//CLONIDINE//SYMPATHETIC NERVOUS SYSTEM DEXMEDETOMIDINE |
7 | 0.0000089612 | GALBULIMIMA ALKALOIDS//GALBULIMIMA BELGRAVEANA//HIMBACINE |
8 | 0.0000088497 | NUCLEUS RAPHE MAGNUS//THALAMIC NUCLEUS SUBMEDIUS//DESCENDING FACILITATION |
9 | 0.0000086180 | XANOMELINE//ALCURONIUM//MUSCARINIC TOXIN |
10 | 0.0000076511 | MUSCARINIC RECEPTOR SUBTYPES//MUSCARINIC RECEPTORS//PIRENZEPINE |